Edroso, Fran Cheska P.

HRN: 19-84-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFUROXIME 750MG (VIAL)
09/25/2025
10/02/2025
IV
680mg
Q8H
PCAP C
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines